Chemotherapeutic Drugs Induce PPAR-γ Expression and Show Sequence-Specific Synergy with PPAR-γ Ligands in Inhibition of Non-Small Cell Lung Cancer

Preclinical studies have shown that peroxisome proliferator-activated receptor γ (PPAR-γ) ligands can exert antitumor effects against non-small cell lung cancer (NSCLC) and a variety of other cancers. In this study, we investigate the potential use of a PPAR-γ ligand, troglitazone (Tro), in combinat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Reddy, Raju C, Srirangam, Anjaiah, Reddy, Kaunteya, Chen, Jun, Gangireddy, Srinivasareddy, Kalemkerian, Gregory P, Standiford, Theodore J, Keshamouni, Venkateshwar G
Format: Artigo
Idioma:Inglês
Publicat: Neoplasia Press Inc. 2008
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2386544/
https://ncbi.nlm.nih.gov/pubmed/18516296
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars